Clinical Trial Update: Effect of Sitagliptin on Endothelial Progenitor Cells [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of sitagliptin on endothelial progenitor cells in type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: University of Padova | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED